Conduent (CNDT) Competitors

Conduent (NASDAQ:CNDT) and NeoGenomics (NASDAQ:NEO) are both small-cap business services companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, community ranking, earnings, media sentiment, institutional ownership, analyst recommendations, profitability, dividends and risk.

Is CNDT or NEO more profitable?

Conduent has a net margin of 12.69% compared to NeoGenomics' net margin of -11.92%. NeoGenomics' return on equity of -2.10% beat Conduent's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conduent	12.69%	-11.39%	-3.21%
NeoGenomics	-11.92%	-2.10%	-1.17%

Does the MarketBeat Community favor CNDT or NEO?

NeoGenomics received 495 more outperform votes than Conduent when rated by MarketBeat users. Likewise, 70.83% of users gave NeoGenomics an outperform vote while only 30.00% of users gave Conduent an outperform vote.

Company	Underperform	Outperform
Conduent	Outperform Votes 15 30.00%	Underperform Votes 35 70.00%
NeoGenomics	Outperform Votes 510 70.83%	Underperform Votes 210 29.17%

Do institutionals and insiders hold more shares of CNDT or NEO?

77.3% of Conduent shares are held by institutional investors. Comparatively, 98.5% of NeoGenomics shares are held by institutional investors. 3.0% of Conduent shares are held by insiders. Comparatively, 2.4% of NeoGenomics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Which has more risk and volatility, CNDT or NEO?

Conduent has a beta of 1.36, indicating that its share price is 36% more volatile than the S&P 500. Comparatively, NeoGenomics has a beta of 1.41, indicating that its share price is 41% more volatile than the S&P 500.

Do analysts rate CNDT or NEO?

NeoGenomics has a consensus price target of $15.72, indicating a potential upside of 146.04%. Given NeoGenomics' stronger consensus rating and higher possible upside, analysts plainly believe NeoGenomics is more favorable than Conduent.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conduent	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
NeoGenomics	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.67

Which has stronger valuation and earnings, CNDT or NEO?

Conduent has higher revenue and earnings than NeoGenomics. NeoGenomics is trading at a lower price-to-earnings ratio than Conduent, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conduent	$3.36B	0.10	$426M	$2.16	0.98
NeoGenomics	$660.57M	1.24	-$87.97M	-$0.62	-10.31

Does the media prefer CNDT or NEO?

In the previous week, NeoGenomics had 23 more articles in the media than Conduent. MarketBeat recorded 28 mentions for NeoGenomics and 5 mentions for Conduent. Conduent's average media sentiment score of 0.89 beat NeoGenomics' score of 0.39 indicating that Conduent is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Conduent	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
NeoGenomics	8 Very Positive mention(s)	3 Positive mention(s)	9 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

NeoGenomics beats Conduent on 11 of the 18 factors compared between the two stocks.